Trials / Completed
CompletedNCT01982916
Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean
A 4 Week Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of AGR Tablet in the Treatment of Perennial Allergic Rhinitis in Korean : a Phase III Clinical Trial Bridging Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 324 (actual)
- Sponsor
- Ahn-Gook Pharmaceuticals Co.,Ltd · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate treatment of perennial allergic rhinitis in Korean patients with AGR tablet.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AGR tablet | |
| DRUG | Placebo (for AGR tablet and/or Active Comparator) | |
| DRUG | Active Comparator |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2015-01-01
- Completion
- 2015-01-01
- First posted
- 2013-11-13
- Last updated
- 2018-03-13
Locations
9 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01982916. Inclusion in this directory is not an endorsement.